|
WO2021062273A1
|
|
Methods of evaluating small molecule-modified polymers in compositions
|
|
WO2021062263A1
|
|
Methods of evaluating polypeptide-modified polymers in compositions
|
|
WO2020198695A1
|
|
Compositions, devices and methods for factor vii therapy
|
|
WO2020198685A1
|
|
Compositions, devices and methods for treating fabry disease
|
|
UY38389A
|
|
IMPLANTABLE DEVICES FOR CELLULAR THERAPY AND RELATED METHODS
|
|
CN112203646A
|
|
Implantable particles and related methods
|
|
WO2019195056A1
|
|
Methods, compositions, and implantable elements comprising stem cells
|
|
WO2019169245A1
|
|
Biocompatible hydrogel capsules and process for preparing same
|
|
US2021060205A1
|
|
Afibrotic compounds, devices, and uses thereof
|
|
CA3077380A1
|
|
Methods, compositions, and implantable elements comprising active cells
|
|
BR112019006712A2
|
|
compound, pharmaceutical composition, composition for use in treating a disease, implantable element, and device.
|
